Cost-effectiveness of health technologies in adults with type 1 diabetes: a systematic review and narrative synthesis.
Anthony Pease, Ella Zomer, Danny Liew, Clement Lo, Arul Earnest, Sophia Zoungas
Syst Rev | Published : 2020
BACKGROUND: With the rapid development of technologies for type 1 diabetes, economic evaluations are integral in guiding cost-effective clinical and policy decisions. We therefore aimed to review and synthesise the current economic literature for available diabetes management technologies and outline key determinants of cost-effectiveness. METHODS: A systematic search was conducted in April 2019 that focused on modelling or trial based economic evaluations. Searched databases included Medline, Medline in-process and other non-indexed citations, EMBASE, PubMed, All Evidenced Based Medicine Reviews, EconLit, Cost-effectiveness analysis Registry, Research Papers in Economics, Web of Science, Ps..View full abstract